10-Q/A

FORM 10-Q/A

Company: Viridian Therapeutics, Inc.\DE
Filed: August 18, 2016
Period of Report: March 31, 2016
Accession Number: 0001171843-16-011863

View Document ↗ View on SEC.gov ↗